Cardinal Health, Inc. Revenue Recognition, Sales Returns, Reserve for Sales Returns
Cardinal Health, Inc. (CAH) reported Revenue Recognition, Sales Returns, Reserve for Sales Returns of $1.80 billion for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-11.
Financial Statements › Notes
us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns · last filed 2026-08-11
- Cardinal Health, Inc. revenue recognition, sales returns, reserve for sales returns for fiscal 2026 was $1.80B, a 18.18% decline from fiscal 2025.
- Cardinal Health, Inc. revenue recognition, sales returns, reserve for sales returns for fiscal 2025 was $2.20B, a 0.00% change from fiscal 2024.
- Cardinal Health, Inc. revenue recognition, sales returns, reserve for sales returns for fiscal 2024 was $2.20B, a 0.00% change from fiscal 2023.
- Cardinal Health, Inc. revenue recognition, sales returns, reserve for sales returns for fiscal 2023 was $2.20B, a 8.33% decline from fiscal 2022.
| Period end | Revenue Recognition, Sales Returns, Reserve for Sales Returns 12 month |
|---|---|
| 2026-06-30 | $1.80B 10-K · filed 2026-08-11 |
| 2025-06-30 | $2.20B 10-K · filed 2026-08-11 |
| 2024-06-30 | $2.20B 10-K · filed 2026-08-11 |
| 2023-06-30 | $2.20B 10-K · filed 2024-08-14 |
| 2022-06-30 | $2.40B 10-K · filed 2024-08-14 |
| 2021-06-30 | $2.60B 10-K · filed 2023-08-15 |
| 2020-06-30 | $2.30B 10-K · filed 2022-08-11 |
| 2019-06-30 | $2.20B 10-K · filed 2021-08-16 |
| 2018-06-30 | $2.40B 10-K · filed 2020-08-13 |
| 2017-06-30 | $2.30B 10-K · filed 2019-08-20 |
| 2016-06-30 | $2.20B 10-K · filed 2018-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |